Tag: Venous disease

Venovo venous stent returns to US market after 2021 recall

BD recently announced that its Venovo venous stent is back on the U.S. market following a recall last year. In 2019, the company reported that the...
top 10 vascular specialist

The top 10 most popular Vascular Specialist stories in April 2022

The digital version of the April 2022 issue of Vascular Specialist, the most recent editorial by our medical editor focusing on diversity within the...

CX 2022: Overtreatment in venous disease: Financial incentives are ‘the elephant...

To combat the “overtreatment problem” in the appropriate care of venous disease, “a concerted, complex, multimodal effort” is required from specialists across disparate parts...

Select gene SNPs found to be associated with venous ulcer formation...

Looking to the future, genetic testing may play a role in guiding the intensity of therapeutic interventions and preventive strategies in patients with venous...

New JVS editorial leadership structure announced

The Executive Board of the Society for Vascular Surgery (SVS) recently revealed the new composition of the Journal of Vascular Surgery (JVS) publications‘ senior...

Venous stents remain durable following pregnancy, researchers find

Iliac vein stents tolerate a gravid uterus well and a possible future pregnancy should not contraindicate their usage in the treatment of pelvic venous...

AVF 2022: Emerging autogenous venous valve formation system sees ‘continual improvement’

An emerging endovenous valve formation system designed to treat patients with chronic venous insufficiency (CVI) with evidence of deep venous reflux has demonstrated continual...

AVF 2022: VenoValve improvement ‘maintained’ for 2.5 years without adverse events

Envveno Medical announced positive 30-month data from the first-in-human trial of the VenoValve bioprosthetic potential venous valve replacement during the 2022 American Venous Forum (AVF)...

Risk of venous stent migration ‘rare’ but probably ‘underreported,’ systematic review...

Stent migration following treatment of acute iliofemoral thrombus or venous obstruction is “rare but may be underreported,” with the majority of reported cases being...

Office-based laboratory setting proves ‘safe’ for iliac vein stenting

A retrospective study of 1,223 iliac vein cases performed in three office-based laboratories (OBLs) demonstrated a major complication rate of 0.41%, suggesting these procedures...

Thrombolex: Investigational RESCUE trial yields ‘exciting’ interim data

The prespecified interim analysis of the first 62 evaluable pulmonary embolism (PE) patients enrolled in the investigational RESCUE trial produced positive results, Thrombolex has...

Europe: ESVS publishes 2022 guidelines on management of chronic venous disease...

The European Society for Vascular Surgery (ESVS) has released 2022 clinical practice guidelines on the management of chronic venous disease (CVD) of the lower...

VIVID study on Duo venous stent system now fully enrolled, Vesper...

Vesper Medical recently announced the completion of enrollment in its pivotal study—VIVID (Venous stent for the iliofemoral vein investigational clinical trial using the Vesper Duo venous stent...

FDA approves two pediatric venous thromboembolism indications for rivaroxaban

The Food and Drug Administration (FDA) has approved two pediatric indications for Xarelto (rivaroxaban): the treatment of venous thromboembolism (VTE) and reduction in the risk of recurrent...

Venous disease: SVS DEI Committee seeks survey participants

The Society for Vascular Surgery (SVS) Diversity, Equity and Inclusion (DEI) Committee is calling on vascular surgeons to complete a survey focused on patterns...

Study: Early thrombosis after iliac stenting for venous outflow occlusion is...

Fewer than 10 days of low-molecular-weight heparin (LMWH) after stenting for extensive iliofemoral venous occlusion prior to transition to oral anticoagulation reduces early thrombosis,...

Three-year VIVO results back ‘continued safety and effectiveness’ of Zilver Vena...

Three-year results of the VIVO clinical study support the continued safety and effectiveness of the Zilver Vena venous stent (Cook Medical) in the treatment of symptomatic...

Registry data show greater clot chronicity on post-procedure inspection than initially...

Nearly half of patients deemed pre-procedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more”...

The top 10 most popular Vascular Specialist stories in August

Our recent editorial on the status of the interview, one of the Presidential Addresses from the Vascular Annual Meeting (VAM), a slew of new...

‘The future is very bright for venous valve replacement’

The progress of two “promising” new devices in the venous valve replacement space were outlined during a Vascular Annual Meeting (VAM) special session co-hosted...

Study shows increase in risk of renal failure following lytic therapy...

A large, single-centre retrospective study has revealed the risk of acute kidney injury (AKI) following pharmacomechanical thrombolysis (PMT) for lower-extremity deep vein thrombosis (DVT)...

Boston Scientific and BD initiate venous stent recalls

Boston Scientific and BD have both initiated recalls of venous stents. According to a Food and Drug Administration (FDA) medical device recall notice posted...

The top 10 most popular stories from April

Our April cover story on the links between electronic health records (EHRs) and physician burnout, the continuing problem of manels (or all-male speaking panels)...

New data support ‘routine’ use of IVUS during iliac vein stenting...

A recent study on iliac vein stenting showed better short and mid-term patency rates when intravascular ultrasound (IVUS) was utilized prior to stent deployment...

Researchers recommend national registries address geographical variation in DVT guideline implementation

A new review concludes that the implementation of clinical guidelines for the management of patients with deep vein thrombosis (DVT) varies among countries, from strict...

Study: ELVeS Radial varicose vein laser therapy shows ‘excellent’ long-term results

ELVeS Radial laser system Long-term results of patients who underwent outpatient laser treatment for varicose veins at the great saphenous vein (GSV) or small saphenous...

Vesper Medical announces first enrollment in the VIVID trial

Vesper Medical recently announced initiation of its Food and Drug Administration (FDA) investigational device exemption (IDE) study, VIVID (Venous stent for the iliofemoral vein investigational clinical trial...

AVF schedules education series for trainees, early-career practitioners

The American Venous Forum (AVF) is to stage a four-part series of educational sessions running the gamut of venous disorders aimed at residents, fellows...

Women are at a higher risk of iliac vein stent failure,...

A recent study on iliac vein stenting showed lower long-term patency rates for women when compared to their male counterparts. The data were presented...

Dispatches from the vascular front: A vascular nursing perspective in times...

For almost the first month after COVID-19 hit New Orleans with a vengeance, vascular nurse Jayme Boudreaux, APRN, found herself largely stuck at home,...

Elder statesman of venous disease delivers golfing metaphor for fortitude, wellness

AMELIA ISLAND, Fla.—As a podium talk at the annual meeting of the American Venous Forum (AVF), it represented a bit of an outlier. It...